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There is a high demand for developing methods to produce more native-like 3D corneal structures. In the
present study, we produced 3D cornea-mimicking tissues using human stem cells and laser-assisted
bioprinting (LaBP). Human embryonic stem cell derived limbal epithelial stem cells (hESC-LESC) were
used as a cell source for printing epithelium-mimicking structures, whereas human adipose tissue
derived stem cells (hASCs) were used for constructing layered stroma-mimicking structures.
The development and optimization of functional bioinks was a crucial step towards successful bio-
printing of 3D corneal structures. Recombinant human laminin and human sourced collagen I served as
the bases for the functional bioinks. We used two previously established LaBP setups based on laser
induced forward transfer, with different laser wavelengths and appropriate absorption layers. We bio-
printed three types of corneal structures: stratiﬁed corneal epithelium using hESC-LESCs, lamellar
corneal stroma using alternating acellular layers of bioink and layers with hASCs, and ﬁnally structures
with both a stromal and epithelial part. The printed constructs were evaluated for their microstructure,
cell viability and proliferation, and key protein expression (Ki67, p63a, p40, CK3, CK15, collagen type I,
VWF). The 3D printed stromal constructs were also implanted into porcine corneal organ cultures.
Both cell types maintained good viability after printing. Laser-printed hESC-LESCs showed epithelial
cell morphology, expression of Ki67 proliferation marker and co-expression of corneal progenitor
markers p63a and p40. Importantly, the printed hESC-LESCs formed a stratiﬁed epithelium with apical
expression of CK3 and basal expression of the progenitor markers. The structure of the 3D bioprinted
stroma demonstrated that the hASCs had organized horizontally as in the native corneal stroma and
showed positive labeling for collagen I. After 7 days in porcine organ cultures, the 3D bioprinted stromal
structures attached to the host tissue with signs of hASCs migration from the printed structure. This is
the ﬁrst study to demonstrate the feasibility of 3D LaBP for corneal applications using human stem cells
and successful fabrication of layered 3D bioprinted tissues mimicking the structure of the native corneal
tissue.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The cornea is the transparent anterior part of the eye, which is
essential for vision. Corneal blindness due to trauma or diseases
affects millions of people worldwide. In the most severe cases, the).
Ltd. This is an open access article ulimbus, a niche for epithelium-renewing limbal epithelial stem
cells (LESCs), is destroyed, resulting in limbal stem cell deﬁciency
(LSCD) with overgrowth of the conjunctiva and blood vessels, se-
vere pain and photophobia [1]. In these patients, the traditional
corneal transplants from deceased donors have poor long-term
success due to lack of epithelial renewal [2,3]. Delivery of in vitro
expanded autologous LESCs to the corneal surface has been intro-
duced as is a possible treatment for patients suffering from uni-
lateral or partially bilateral LSCD [4,5]. Even more advancednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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equivalents for bilateral LSCD. Furthermore, the underlying
corneal stroma is often damaged especially in cases of traumatic
corneal blindness, and requires a replacement to restore visual
function. Thus, there is an increased demand for developing
methods to produce more native-like 3D corneal structures using
human stem cells and functional biomaterials. Tissue engineering
has sought to answer this ever-increasing demand by creating
chemically deﬁned cell and biomaterial based products to treat and
cure corneal blindness.
Biomaterials for corneal stromal reconstruction are required to
integrate with the host tissue, be functionally transparent and
mechanically stable. For biologically functional corneal tissue
equivalents, these materials require a cell density and 3D organi-
zation similar to that of the native cornea. Functional corneal
stromal tissue has previously been fabricated by seeding human
cells into decellularized porcine [6] or human cornea stromal tissue
[7] or stimulating human cells to secrete their own extracellular
matrix and produce corneal tissue equivalents [8]. However, use of
decellularized tissue still lacks established methods for complete
removal of antigenic moieties while maintaining proper tissue
integrity [9], whereas the tissue equivalents secreted by human
cells are slow to manufacture and limited to only thin or stacked
constructs [10].
Corneal tissue in general is an optimal target for tissue engi-
neering and 3D bioprinting technology due to its relatively low
thickness [11] and lack of vascularization, which has limited the use
of 3D printing technology in many other applications, such as bone,
heart or skin tissue [12,13]. 3D bioprinting is a promising technique
for fast production of thick corneal constructs, but previous work in
the ﬁeld has been conducted with immortalized corneal epithelial
cells without any epithelial organization [14]. The applied nozzle-
free laser-assisted bioprinting (LaBP) method allows high resolu-
tion printing of bioinks with high viscosity and high cell density
without affecting the viability of the cells, while being capable of
high printing resolution (<10 pL droplets) [15e17]. To reach high
resolution with nozzle-based printing techniques, such as extru-
sion or ink jet printing, small nozzles (<100 mm diameter) are
needed, which prevent the use of high cell density due to high
shear stress to the cells. Furthermore, with LaBP, we can achieve
precise spatial organization of cells and use different cell types in
the same engineered structure. In any 3D bioprinting application, a
suitable bioink is needed to produce shape-retaining multilayered
corneal structures. For production of clinically relevant corneal
structures, it is crucial to develop new functional bioinks based on
xeno-free components, as well as suitable regenerative cell types.
Human pluripotent stem cells (hPSCs) can provide almost lim-
itless amounts of LESC-like cells, with gene and protein expression
similar to native LESCs [18,19]. With our recently established
feeder-cell free hPSC culture and differentiation protocol [20], we
have further brought our LESC differentiation towards a clinically
relevant method for regeneration of the ocular surface. For recon-
struction of the corneal stroma, human adipose tissue derived stem
cells (hASCs) have gathered wide attention due to their high
availability from healthy adult donors, as well as their capability to
differentiate towards corneal keratocytes, which has been
demonstrated in both in vitro [21e23] and in vivo [24,25] studies.
Furthermore, autologous hASCs have already reached clinical pilots
for treating corneal stromal disorders [26]. In addition, hASCs have
excellent immunomodulatory properties, reducing inﬂammation at
the site of implantation [27] as well as anti-scarring properties
[28,29]. With these two different stem cell types, we can produce a
tissue engineered corneal structure, which could simultaneously
replace the damaged corneal stroma and regenerate the corneal
epithelium.In the present study, we produced 3D corneal mimicking tissues
using human stem cells, functional bioinks and LaBP. Human em-
bryonic stem cell (hESC) derived LESCs were the cell source for
printing corneal epithelium-mimicking structures, whereas hASCs
were the cellular component in lamellar corneal stromal tissues.
We chose human sourced collagen I and recombinant human
laminin as bases for the bioinks to develop clinically suitable
techniques for corneal tissue engineering. Here, we demonstrate
the feasibility of 3D LaBP for corneal applications and show suc-
cessful fabrication of layered 3D bioprinted tissues from both
investigated cell types that resemble the structure of the native
corneal tissues.
2. Experimental methods
2.1. Bioinks
For hESC-LESCs, bioink containing human recombinant laminin-
521 (LN521; Biolamina, Sweden) was chosen, as laminin is a major
component in LESC basement membrane in the native cornea [30].
The hESC-LESC bioink consisted of 33% of 0.1mg/ml LN521, 50% of
deﬁned and serum-free CnT-30 medium (CELLnTEC Advanced Cell
Systems AG, Bern, Switzerland) supplemented with RevitaCell™
(100x) (Gibco, Life technologies) at a 1X ﬁnal concentration, and
17% of 1 w/v% Hyaluronic acid sodium salt (HA) from Streptococcus
equi saline (Mw¼ 1.5e1.8 106 Da) (Sigma Aldrich, Deisenhofen,
Germany) in Tris-buffered saline (TBS).
Human collagen I (Col I) was used as a base of the bioink for
hASCs as it is the primary component of the human corneal stroma
[31]. OptiCol™ Human Collagen Type I (3mg/ml) (Cell Guidance
Systems Ltd, Cambridge, UK) was neutralized to a pH of 7.4 with
0.25 N sodium hydroxide (NaOH) in the presence of 10X Dulbecco's
Phosphate Buffered Saline (DPBS, Carl Roth, Karlsruhe, Germany).
The bioink for hASCs included 44.4% of neutralized human Col I,
22.2% of ethylenediaminetetraacetic acid (EDTA) human female AB
blood plasma, 22.2% of 40 IU/ml Thrombin from human plasma
(Sigma Aldrich, Deisenhofen, Germany) in 0.1M TBS and 11.1% of
10x DBPS. The human plasma was extracted with EDTA tubes, from
blood collected from venipunctures and centrifuged at 4500 U/min
for 30min. Thereafter, human plasma was collected and sterile
ﬁltrated.
For 3D structures, acellular layers without hASCs were printed
between hASCs in order to establish corneal stromal mimicking
structures. There, a bioink with 40% of neutralized human Col I, 20%
of human plasma, 20% of thrombin, 10% of 1 w/v% HA and 10% of
10x DBPS was used. The speciﬁc concentrations for the used re-
agents are listed above.
2.2. In vitro degradation
Degradation kinetics of the collagen-based hASC bioink in both
cell culture medium and varying concentrations of collagenase
were determined by weighing the gelled acellular bioink at
different time points. For this purpose, the acellular bioink was
prepared, as described in Section 2.1, by mixing bioink components
to a total volume of 200 ml into 48-wells and allowed to gel for
2e3 h. The gels were then transferred to larger wells for degrada-
tion studies in either EBM-2 medium (Lonza, Basel, Switzerland) or
in 0.1M Tris-HCl buffer, pH 7.4, supplemented with 5mMCaCl2 and
0.005 (w/v) NaN3, containing 0 U/ml, 5 U/ml, 50 U/ml, or 250 U/ml
of collagenase (collagenase type I, CLS I, from Clostridium histo-
lyticum; Biochrom, Berlin, Germany) and stored in an incubator at
37 C. The initial weight of the gels was recorded and they were
subsequently weighed at different time points up to 8 days (in
medium) or 6 h (in collagenase), respectively. Degradation studies
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2.3. Human embryonic stem cell derived limbal epithelial stem cells
Previously established hESC line Regea08/017 (XX) [32] was
used for LESC differentiation as previously described [20]. In brief,
undifferentiated hESCs were maintained on well-plates coated
with 1.09 mg/cm2 LN521 in Essential 8™ Flex Medium (E8, Thermo
Fisher Scientiﬁc) supplemented with 50 U/ml Penicillin-
Streptomycin (Gibco, Thermo Fisher Scientiﬁc). For LESC differen-
tiation, hESCs were enzymatically detached and transferred to
Corning® Costar® Ultra-Low attachment plates in XF-ko-SR me-
dium (KnockOut™ DMEM supplemented with 15% KnockOut™ SR
XenoFree CTS™ (XF-ko-SR), 2mM GlutaMAX™, 0.1mM 2-
Mercaptoethanol, 1% MEM Non-Essential Amino Acids, and 50 U/
ml Penicillin-Streptomycin (all from Gibco, Thermo Fisher Scienti-
ﬁc)) supplemented with 5 mM blebbistatin (Sigma-Aldrich) over-
night to induce embryoid body formation. The following day, the
embryoid bodies were guided towards surface ectoderm with one
day in XF-ko-SRmedium supplemented with 10 mM SB-505124 and
50 ng/ml human basic ﬁbroblast growth factor (PeproTech Inc.,
Rocky Hill, NJ) followed by two days in XF-ko-SR medium supple-
mented with 25 ng/ml bone morphogenetic protein 4 (PeproTech
Inc.). Subsequently, the embryoid bodies were seeded onto 0.75 mg/
cm2 LN521 and 5 mg/cm2 collagen IV coated well-plates in CnT-30
medium and cultured for 22e24 days. Finally, differentiated
hESC-LESCs were cryopreserved in PSC Cryopreservation Medium
(Thermo Fisher Scientiﬁc).
For printing, the cryopreserved hESC-LESCs were thawed onto
0.75 mg/cm2 LN521 and 5 mg/cm2 human collagen IV coated well
plates in CnT-30 medium supplemented with RevitaCell™ (100X)
(Gibco, Life technologies) at a 1X ﬁnal concentration and cultured
overnight. The following day, the medium was replaced with CnT-
30, and hESC-LESCs were cultured for six to seven days before
enzymatically detaching cells with TrypLE™ for printing. After
4min incubation in TrypLE™, the enzyme was removed, and
Deﬁned Trypsin Inhibitor (DTI) (Thermo Fischer Scientiﬁc) was
added to inactivate any remaining enzyme. Human ESC-LESCs were
gently detached with a cell scraper in DTI and centrifuged. Subse-
quently, the supernatant was removed and cells counted in CnT-30
medium. Appropriate amount of cells was aliquoted in Eppendorf
tubes, and centrifuged. The supernatant was removed, and hESC-
LESCs were resuspended in LN521 containing bioink and used for
LaBP with cell density of 30 106 cells/ml.
2.4. Human adipose derived stem cells
Human ASCs were isolated mechanically and enzymatically
from subcutaneous adipose tissue samples of a female donor un-
dergoing elective plastic surgery at Tampere University Hospital
(Tampere, Finland) according to previously published protocols
[33,34]. The isolated hASCs were characterized for their surface
marker expression by ﬂow cytometry (FACSAria; BD Biosciences,
Erembodegem, Belgium) as previously described [34]
(Supplementary Table S1).
The hASCs were cultured in EBM-2 Medium (Lonza, Basel,
Switzerland) devoid of fetal bovine serum and supplemented with
2% human serum (type AB male, HIV tested from BioWest, Nuaille,
France). This medium was selected to maintain hASC in their un-
differentiated state during in vitro culture. Human ASCs were
passaged upon conﬂuency using TrypLE™ and used for LaBP at
passages 3e5. For printing, hASCs were enzymatically detached
with TrypLE™, centrifuged and resuspended in culture medium for
counting. Thereafter, hASCs were centrifuged in Eppendorf tubes,
supernatant was removed and the cells were resuspended inhuman Col I based bioink with a cell density of 30 106 cells/ml for
LaBP.
2.5. Laser-assisted bioprinting of human stem cells
Here, we used laser-assisted bioprinting (LaBP) based on laser
induced forward transfer (LIFT). A detailed description of the LaBP
setup has been previously published [15]. In brief, the setup con-
sists of a pulsed laser source and two horizontal co-planar glass
slides (26 26mm2). The upper one, referred to as donor slide, is
coated with a thin laser-absorbing layer (two different laser
absorbing materials were used in this study) and, subsequently,
with a thicker layer of the bioink to be printed. This bioink is usually
a sol (the non-gelled precursor of a hydrogel) with embedded cells.
The donor slide is mounted upside-down in the printing setup
(Supplementary Fig. S1) and laser pulses are focused through the
donor slide into the absorption layer, which is evaporated in the
laser focus. An expanding vapor bubble is generated at the immo-
bile donor slide surface that propels the subjacent biomaterial to-
wards the second glass slide, referred to as collector slide, or an
arbitrary object to print onto. Due to the collapsing of the vapor
bubble after a few microseconds and inertia, the bioink forms a jet
that lasts for a few hundred microseconds. This jet impinges on the
collector slide and deposits as a small droplet in the picoliter vol-
ume range (a few ten to a few hundred microns in diameter) on the
collector slide. By moving the laser focus, the donor and collector
slides relative to each other, bioink droplets are positioned in
speciﬁc patterns. Thus, 3D structures from the bioink can be pro-
duced by repeating this procedure layer-by-layer [35]. The depo-
sition of the bioink is controlled via computerized scanning setup
[15]. In this study, we used two laser-based printing systems with
different laser wavelengths and appropriate absorption layer ma-
terial. In the ﬁrst setup, a Nd:YAG-laser (DIVA II; Thales Laser, Orsay,
France) with 1064 nm wavelength, 10 ns pulse duration and 20 Hz
repetition rate was combined with a 60 nm thin gold absorption
layer. The second system applied an Er:YAG-laser (DPM-15, Pantec
Engineering AG, Ruggell, Liechtenstein) with 2940 nmwavelength,
3 ms pulse duration, and up to 1 kHz repetition rate (500 Hz was
used within this study); this wavelength ﬁts into an absorption
maximum of water making it optimal for hydrogel absorption
layers. The ﬁrst printing setup was applied for printing hESC-LESCs,
and hASCs in both 2D and 3D structures, whereas the latter was
used for constructing 3D cornea-mimicking structures with both
cell types. The laser pulse energy was adjusted for both cell types
under investigation. All printing experiments were carried out at
room temperature (RT) under humid environment.
For hESC-LESC printing, an additional transparent polyethylene
terephthalate (PET) ﬁlm with 0.4 mm pores (Sarstedt, Nümbrecht,
Germany) coated with 0.75 mg/cm2 LN521 and 5 mg/cm2 human
Collagen IV (Col IV) was placed on the collector glass slide. 50 ml of
laminin-containing bioink with hESC-LESCs was spread on the
donor layer, resulting in approximate layer thickness of 74 mm.
7 mm  7 mm samples were printed with a speed of 5000 mm/s.
Three layers of hESC-LESCs were printed on top of each other, using
laser pulse energy of 18 mJ. The samples were allowed to stabilize
at þ37 C for 30 min before adding CnT-30 medium supplemented
with 1X RevitaCell™. The following day, the medium was replaced
with fresh CnT-30 mediumwithout RevitaCell™. The printed hESC-
LESCs were cultured for up to 12 days and the culture mediumwas
changed three times a week.
Human ASCs were printed in 2D patterns in order to evaluate
the viability of the cells after LaBP. Collector slides were coatedwith
Corning® Matrigel® Basement Membrane Matrix (Fisher Scientiﬁc
GmbH, Schwerte, Germany). The Matrigel® was diluted in 2:1 ratio
in EBM-2 cell culture medium. 75 ml of diluted Matrigel® was
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at þ37 C. 45 ml of the human Col I containing bioink with hASCs
was spread on the donor slide resulting in approximate layer
thickness of 67 mm. First, hASCs were printed in lines (with 500 mm
spacing), or in spots (with 400 mm spacing) with the speed of
2000 mm/s and laser pulse energy of 20 mJ. The printed samples
were allowed to stabilize for 10 min at þ37 C before submerging
them in cell culture medium.
For creating 3D corneal stromal mimicking structures, alter-
nating layers of hASCs and acellular layers 7mm 7mm in size
were printed with a speed of 5000 mm/s. Laser pulse energy of 20 mJ
was used for hASC-containing bioink, while acellular layers were
printed with higher laser pulse energy of 25 mJ. 45 ml of the hASC-
containing bioink was applied on the donor slide resulting in
approximate layer thickness of 67 mm, and 65 ml of the acellular
bioink yielded a 96 mm thin layer on the donor slide. Two consec-
utive layers of hASC-containing bioink were laser-printed, followed
by four acellular layers. All cell-containing layers in the 3D bio-
printed stromal structures were printed in the same orientation. In
total, 10 alternating layers of hASCs and acellular bioink were
printed in layer-by-layer manner to create a thick 3D structure, as
illustrated in Fig. 1. In total, the 3D laser-printed stromal mimicking
structures consisted of 60 printed layers. The 3D stromal mimicking
structures were printed on a stabilizing matrix, Matriderm® (Dr.
Suwelack Skin & Health Care, Billerbeck, Germany). Matriderm®
sheets are nontransparent collagen-elastin matrixes with 1mm
thickness. Matriderm® sheets have been previously used as a sta-
bilizing matrix for Col-based bioinks and hASCs in skin applications
[15]. The structures were allowed to stabilize at þ37 C in humid
environment for 1 h before submerging them in the EBM-2 culture
medium. Thereafter, the printed stromal structures were cultured
for 14 days and fresh medium was changed three times a week.
Finally, we combined the two cell types to establish a proof-of-
concept for 3D bioprinting human corneal mimicking structures
from human stem cells. For this, the second bioprinting system
based on LaBP was used in combination with a laser absorption
layer composed of 18 ml Matrigel® and 2 ml glycerol, blade coated on
a glass donor slide. Matrigel® was chosen, since Matrigel® gels
relatively quickly at þ37 C, possess a hydrophilic surface and is
biocompatible, while glycerol avoids fast drying of the layer before
the bioink is applied on top. The applied human Col I-based bioink
gelates very slowly and is thus not optimal as laser absorption layer.
The concentration of Matrigel® in the ﬁnal printed construct was
approximately 0.4 ml/cm2. On top of the absorption layer, 50 ml of
bioink with suspended cells was spread (for printing, the donorFig. 1. Schematic diagram of the laser-assisted bioprinting system and printing of the
3D stromal mimicking structures. Stromal mimics comprised 10 alternating layers of
hASCs and acellular bioink, with each individual cell-containing layer consisting of two
layers of hASCs and the acellular layer consisting of four printed layers.slide was turned upside-down). Laser pulse energies of 150 mJ were
applied, which are not directly comparable to those of the ﬁrst
bioprinting setup due to the different wavelength, laser pulse
duration, and absorption material. Again, 7 7mm2 samples were
printed, here with a speed of 7000 mm/s and 100 mm line spacing.
The same cell densities and bioinks described above were used for
both hESC-LESCs and hASCs. The 3D corneal mimicking structures
were allowed to stabilize at þ37 C for 1 h before submerging them
in culture medium. For these samples, a medium consisting of 1:1
ratio of CnT-30 with 1X RevitaCell™ and EBM-2 with 2% HS was
used. Both PET and Matriderm® sheets were used as stabilizing
substrates. The next day, same medium without RevitaCell™ was
changed, and the structures were cultured for up to 3 days.
2.6. Cell viability
Cell viability and proliferation of both hESC-LESCs and hASCs
after LaBP were assessed with two commercially available assays e
LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells and
PrestoBlue™ cell viability reagent (both from Thermo Fischer Sci-
entiﬁc), according to manufacturer's instructions. The hESC-LESC
viability with LIVE/DEAD® kit was determined after 3 and 7 days
of printing, whereas cell viability of hASCs was analyzed the
following day. PrestoBlue™ viability assay was performed at days 1
and 7 for hESC-LESCs, at days 1 and 4 for hASCs printed in 2D
patterns, and at days 1, 4 and 7 for hASCs printed in 3D stromal
mimicking structures. For hESC-LESCs, eight samples with four
technical replicates were analyzed in each time point. For hASCs
printed in 2D patterns, in total 20 samples with four technical
replicates were analyzed in both time points. Finally, four to six 3D
bioprinted stromas with hASCs with four technical replicates were
included in cell proliferation analysis at each time point. Moreover,
cell morphology was inspected daily with phase contrast
microscope.
2.7. Indirect immunoﬂuorescence staining
The cell migration, cell morphology, expression of cell speciﬁc
markers and tissue structure after LaBP were investigated with
immunoﬂuorescence (IF) stainings. For hESC-LESCs and hASCs
printed in 2D patterns, the IF staining was done as previously
described [36]. Primary antibodies rabbit anti-Ki67 1:200 (Milli-
pore), rabbit anti-p63a 1:200 (Cell Signaling Tech), mouse anti-p40
1:200 (Biocare Medical), mouse anti-CK3 1:200 (Abcam) and
mouse anti-CK15 (Thermo Fischer Scientiﬁc) were investigated for
hESC-LESCs. Primary antibody detectionwas donewith Alexa-Fluor
conjugated 488 donkey anti-mouse IgG, 488 donkey anti-rabbit IgG
and 568 donkey anti-rabbit IgG (all from Molecular Probes, Life
Technologies). All secondary antibodies were diluted 1:400.
Phalloidin-Atto 550 1:100 (Sigma Aldrich) was used for visualizing
the ﬁlamentous actin cytoskeleton of the cells and mounting me-
dium containing 40,6-diamidino-2-phenylindole (DAPI; Vecta-
Shield, Vector Laboratories Inc., Burlingame, CA) was used for
staining the nuclei.
The 3D bioprinted structures as well as human corneal samples
were rinsed twice with DPBS, and ﬁxed in 4% PFA for 1 h at RT.
Subsequently, the 3D samples were rinsed with PBS and incubated
in 20% sucrose solution overnight at þ4 C. The next day, the
samples were embedded in Tissue-Tek OCT (Science Services,
Munich, Germany) and snap frozen at 80 C. For IF and other
histological stainings, cryosections of 7 mm were prepared and air
dried for 1 h at RT. Thereafter, the cryosections were incubated in
3% BSA-PBS and 0.1% Triton-X-100 for 1.5 h at þ37 C. Primary
antibody dilutions were prepared in 3% BSA-PBS and incubated
overnight at þ4 C under humid conditions: rabbit anti-Ki67 1:200
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von Willebrand Factor (VWF) 1:200 (Dako Cytomation) and mouse
anti-p40 1:200 were used. Primary antibody detection was done
with the same secondary antibodies as described above 1:400 in 3%
BSA-DPBS for 1.5 h at þ37 C. In addition, ﬁlamentous actin was
stained with Phalloidin Tetramethylrhodamine B isothiocyanate
1:400 (Sigma Aldrich). Finally, the samples were thoroughly
washed with PBS and mounted with ProLong™ Gold Antifade
Mountant (Thermo Fischer Scientiﬁc) with DAPI to stain the nuclei.
The IF samples were imaged with AxioScope A1 ﬂuorescence
microscope (Carl Zeiss) or LSM 700 confocal microscope (Carl Zeiss,
Jena, Germany) and images edited using ZEN 2011 Light Edition
(Carl Zeiss) and Corel® Photo-Paint X8.
2.8. Hematoxylin and eosin staining
Hematoxylin and eosin (HE) staining was carried out for sec-
tions from the 3D bioprinted structures as well as corneal samples.
HE staining was carried out following standard procedures for
cryosections and parafﬁn embedded sections, and observed under
a Nikon Eclipse TE200S microscope (Nikon Instruments Europe
B.V., Amstelveen, Netherlands).
2.9. Corneal organ cultures
The corneal organ culture using excised porcine corneas was
conducted as previously described [37e39]. Brieﬂy, fresh porcine
eyes were stripped of excess tissue and disinfected with 2% povi-
done iodine (Betadine®, Leiras, Helsinki, Finland), and the corneas
were dissected from the eyes in aseptic conditions. The corneas
were cultured partially submerged in CnT-Prime-CC medium
(CELLnTECH Advanced Cell Systems AG) supplemented with 1%
Penicillin-Streptomycin, 0.25 mg/ml amphotericin B (Thermo Fisher
Scientiﬁc) and 5 mg/ml Plasmocin (InvivoGen, Toulouse, France)
at þ37 C in 5% CO2 for two weeks prior to implantation of the 3D
bioprinted stromal constructs.
Two-day-old 3D printed stromal structures on the Matriderm®
substrate were shipped from Germany to Finland overnight
at þ37 C in EBM-2 medium containing 20 mM HEPES, and
implanted into the corneal organ cultures 4 days after printing.
Implantationwas performed on a Barron artiﬁcial anterior chamber
(Katena products Inc., Denville, NJ, USA), to allow handling of the
cornea during the operation. Corneal epithelium was scraped off
using a scalpel (Feather Safety Razor co., ltd, Osaka, Japan), and a
5 mm trephine (Robbins Instruments, Chatham, NJ, USA) was used
to make a partial thickness cut to the center of the cornea. The
stromal tissue was removed from the trephined area using a cres-
cent knife (Bauch&Lomb Inc., Rochester, NY, USA). The trephinewas
also used to punch out a 5 mm diameter piece from the 3D printed
stromal construct, which was placed into the stromal wound bed
with the bioprinted stromal side facing downwards. Matriderm®
substrate alone and acellular bulk-formed bioink gels were
implanted as negative controls. Although constructs did not with-
stand suturing in place, it was deemed unnecessary due to the static
culture conditions and the ﬁtted trephination of the implant and
the wound site. After implantation, the corneas were moved from
the artiﬁcial anterior chamber back into culture plates, covered
with soft contact lenses (EyeQ One-Day Premium, Cooper Vision,
Hamble, UK), and cultured partially submerged in EBM-2 medium
with 2% HS for 7 days, at þ37 C in 5% CO2.
One week after implantation, the corneal organ cultures were
ﬁxed in 4% PFA for 4 h at RT, dehydrated in Tissue-Tek VIP 5 (Sakura
Finetek Europe) automatic tissue processor overnight, and
embedded in parafﬁn. The parafﬁn blocks were sectioned into 6-
mm-thick slices using a microtome, and the sections were mountedon TOMO® adhesion microscope slides (Matsunami Glass Ind., Ltd.,
Osaka, Japan).
2.10. Immunohistochemical staining
The corneal organ cultures containing 3D bioprinted stromal
constructs and their Matriderm® controls, were analyzed using
immunohistochemical staining against the human cell marker
TRA-1-85 to detect hASCs in the samples. The staining was per-
formed similarly as in Ref. [40], with slight modiﬁcations. Brieﬂy,
samples were deparafﬁnized and hydrated, followed by antigen
retrieval in hot 0.01 M citrate buffer (pH 6.0) for 10 min. Tissue
intrinsic peroxide activity was blocked by incubation in 0.3% H2O2
for 30 min at RT. Ready-to-use 2.5% normal horse serum (Vector
ImmPress reagent, Vector Laboratories Inc.) was used to block un-
speciﬁc binding. Samples were then labeled with anti-TRA-1-85
mouse IgG antibody (courtesy of Peter Andrews, University of
Shefﬁeld) in a 1:100 (v/v) dilution in 0.5% BSA overnight at þ4 C,
and labeled with Vector ImmPress horse anti-mouse IgG (con-
taining horseradish peroxidase) (Vector Laboratories Inc.) for
30 min at RT. Staining was visualized by peroxidation reactionwith
DABþ chromogen system (Dako North America, Inc., Carpinteria,
CA, USA), which was performed for 30 s at RT. The tissue was
counterstained using Harris' hematoxylin, followed by dehydra-
tion, and mounting using Pertex (Histolab, Askim, Sweden). Sam-
ples were imaged using Nikon Eclipse TE200S microscope.
2.11. Statistical analysis
The statistical signiﬁcance of PrestoBlue™ cell proliferation data
was determined with ManneWhitney U test. The mean values of
cell proliferation data for all printed tissues are presented ±stan-
dard error. p-values 0.05 were considered statistically signiﬁcant.
The statistical data analysis was carried out with IBM SPSS Statistics
software.
2.12. Ethical issues
This study was carried out under an approval from the local
ethics committee of the Pirkanmaa hospital district Finland that
allows us to derive and expand hESC lines from surplus embryos
donated by couples undergoing infertility treatments, and to use
these cell lines for research purposes (R05116). In addition, we have
ethical approvals to extract and use hASC for research purposes
(R15161) and to use human donor corneas unsuitable for trans-
plantation for research purposes (R11134). New cell lines were not
derived for this study.
3. Results
3.1. Laser-printed hESC-LESCs remain viable, express key markers
and form mature 3D cornea-like tissue
Initially, laser-printed hESC-LESCs were spherical in
morphology (Supplementary Fig. S2) but recovered their normal
polygonal morphology during culture. The viability of hESC-LESCs
was analyzed with LIVE/DEAD® after 1 and 7 days of printing. In
both investigated time points, the laser-printed hESC-LESCs were
viable in LN521 containing bioink, with only a few dead cells after 7
days of culture (Fig. 2A). In addition, laser-printed hESC-LESCs
showed polygonal epithelial cell morphology at day 7 (Fig. 2B).
Signiﬁcantly higher cell proliferation (p< 0.05) was detected at day
7 after printing compared to cell proliferation at day 1 (Fig. 2C), as
conﬁrmed with PrestoBlue™ assay. To verify the cell phenotype
and organization, IF staining was carried out at day 7. Phalloidin
Fig. 2. 3D laser-assisted bioprinting of hESC-LESCs. Cell viability of hESC-LESCs three and seven days after printing shown with live-dead-staining (A). Live cells are visualized with
green and dead cells with red. Scale bars 1mm. Phase microscope image of printed hESC-LESCs (B). Scale bar 200 mm. Human ESC-LESC proliferation after printing (*p < 0.01) (C).
Immunoﬂuorescence staining of phalloidin (red) and Ki67 (green) illustrating hESC-LESC cell morphology and proliferating cells after seven days of printing (D). Protein expression
of corneal epithelial progenitor markers p63a (green) and p40 (red) in 3D bioprinted hESC-LESCs at day seven (E). Representative vertical confocal image of layered hESC-LESCs (F).
Localization of corneal progenitor markers p63a (green) and p40 (red) in layered hESC-LESCs (G). 3D rotated (H) and top view (I) transparency rendering mode confocal images of
the layered hESC-LESCs. Scale bars 200 mm (D-E) and 50 mm (F-I). The nuclei are visualized with DAPI (blue). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the Web version of this article.)
A. Sorkio et al. / Biomaterials 171 (2018) 57e7162staining of the actin cytoskeleton conﬁrmed the polygonal
epithelial cell morphology of the printed cells seen in phase
contrast microscopy (Fig. 2D). Moreover, the printed hESC-LESCs
expressed the proliferation marker Ki67 (Fig. 2D) and co-
expressed corneal progenitor markers p63a and p40 (Fig. 2E).
Importantly, the printed layers of hESC-LESCs retained epithelium-
like structure with 3e4 cell layers (Fig. 2F) and with p63a and p40
expressed throughout the layered epithelium (Fig. 2G). Finally, 3D
confocal imaging of the day 7 IF samples demonstrated that the
hESC-LESCs retained the 3D epithelial tissue after printing (Fig. 2H
and I). Conversely, stratiﬁed epithelial tissue formation was not
observed for non-bioprinted hESC-LESCs seeded in suspension on
PET substrates after 7 days (Supplementary Fig. S3).The 3D bioprinted hESC-LESCs were further cultured up to 12
days, and subsequently analyzed for maturation with IF. At this
time point, the 3D bioprinted hESC-LESCs demonstrated epithelial
cell morphology (Fig. 3A). Only a few of the printed cells expressed
the proliferation marker Ki67 (Fig. 3A), but expression of corneal
progenitor markers p63a, p40 and CK15 was strong (Fig. 3B and C).
Epithelial cell morphology was also seen in phase contrast micro-
scopy (Fig. 3D). Notably, hESC-LESCs showed maturation towards
corneal epithelial cells, with expression of CK3, a marker for
terminally differentiated corneal epithelium (Fig. 3E). After 12 days,
the printed cells retained a stratiﬁed epithelium with four distin-
guishable cell layers (Fig. 3FeJ). The stratiﬁed structure of the
printed epithelium also demonstrated signs of further maturation
Fig. 3. The maturation of 3D bioprinted hESC-LESCs after 12 days demonstrated with immunoﬂuorescence stainings. A. Cell morphology (phalloidin¼ red) and proliferating cells
(Ki67¼ green). Expression of corneal progenitor markers p63a (green), p40 (red) (B) and CK15 (green) (C). Phase microscope image of hESC-LESCs (D). Expression (E) and apical
localization (F) of CK3 (red), a marker of terminally differentiated corneal epithelium. Representative vertical confocal sections of the layered hESC-LESCs (G) and the basal
localization of the corneal progenitor markers p63a and p40 (H). 3D rotated (I) and top view (J) transparency rendering mode confocal images of the layered hESC-LESCs. Scale bars
200 mm (A-E) and 50 mm (F-J). (DAPI¼ blue). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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CK3 (Fig. 3F) and basal expression of p63a and p40 (Fig. 3H). The 3D
confocal imaging conﬁrmed the 3D epithelial tissue-like structure
12 days after printing (Fig. 3I and J).3.2. hASCs in human Col I based bioink remain viable and
proliferate after LaBP
The biocompatibility of human Col I-containing bioink after
A. Sorkio et al. / Biomaterials 171 (2018) 57e7164LaBP was ﬁrst investigated by printing hASC in organized 2D pat-
terns of aligned lines and spots. The human Col I containing bioink
with hASCs demonstrated good printability and biocompatibility.
The cells demonstrated excellent viability 1 day after printing:
hardly any dead cells were detected in LIVE/DEAD® analysis of
hASCs printed in lines (Fig. 4A) and spots (Fig. 4B). Cell viability was
further conﬁrmed with PrestoBlue™ and IF. The hASCs printed in
line pattern showed signiﬁcantly higher cell proliferation
(p< 0.001) at day 4 compared to day 1. Both printed patterns were
clearly visible on day 1 after printing, with elongated cells
migrating from both patterns (Fig. 4D and E). By day 4, the initial
printed patterns were not visible anymore, as the cells had prolif-
erated and migrated extensively. However, hASCs printed in 2D
lines clearly organized in a uniformly aligned fashion by day 4.
Finally, hASCs printed in both patterns expressed cell proliferation
marker Ki67 at both time points (Fig. 4D and E).
3.3. Laser-printed hASCs form organized corneal stromal mimicking
structures
LaBPwas used for fabricating thicker 3D stromal structures from
hASCs and human Col I-containing bioink. Alternating layers of
hASC-containing bioink and acellular bioink were printed to mimic
the lamellar structure of the human corneal stroma, with each layer
printed with the same orientation (Fig. 1). Initially, the 3D struc-
tures had an approximate thickness of 500 mm in a base area of
7mm 7mm. The viability of the 3D printed structures was
studied with PrestoBlue™ and LIVE/DEAD® staining. Human ASCs
in 3D structures showed signiﬁcantly higher cell proliferation
(p< 0.001) after 4 and 7 days of culture compared to day 1 (Fig. 5A).
Moreover, cell proliferation increased signiﬁcantly (p< 0.05) be-
tween 4 and 7 days of culture. LIVE/DEAD® analysis of the 3D
bioprinted structures demonstrated high cell viability after print-
ing, with the majority of the cells viable throughout the structures
(Fig. 5B and C). Only a few dead cells were detected when viewing
the structures from the top (Fig. 5B), although slightly more dead
cells were seen in the lower part of the structure when examining
the cross-section (Fig. 5C). After 4 days of culture, Ki67 expressing
cells were detected in IF analysis of the frozen sections (Fig. 5D),
conﬁrming the survival and viability of hASCs in 3D bioprinted
structures. Without Matriderm® supportive sheets as a printing
substrate, the printed structures showed extensive shrinkage and
lost their printed form after a few days of culture.
The structure and cellular organization of the 3D bioprinted
grafts were visualized from frozen sections with IF stainings
(Fig. 5EeI) and compared to the structure of the native human
corneal stroma (Fig. 5J and L). In all investigated time points, the
hASCs had organized sparsely throughout the 3D structure. More-
over, some lamellar structures had formed, and hASCs showed
elongated cell morphology. Even though the 3D bioprinted struc-
tures had higher cell density, the cell organization in 3D printed
structures resembled the native human corneal stroma. Further-
more, high-magniﬁcation confocal images demonstrated that the
hASCs had organized horizontally (Fig. 5K) as in the native corneal
stroma (Fig. 5L). The thickness of the printed structures decreased
slightly in culture: after 14 days, structures with thickness of
300 mm remained. When analyzing the cell organization in the
printed structures from the top, a clear orientation of the cells was
detected (Fig. 5M and N). The hASCs in the outermost layer were
organized as an aligned cell layer (Fig. 5M), with almost perpen-
dicular orientation to the layer directly underneath (Fig. 5N). 3D
confocal images of the printed corneal stromal mimicking struc-
tures also conﬁrmed the cellular organization into lamellae
(Fig. 5O) with aligned cells (Fig. 5P). In addition, HE staining of the
frozen cross-section of 3D bioprinted grafts after 7 days (Fig. 5Q)demonstrated the lamellar structure of the matrix and cells similar
to the human corneal stroma (Fig. 5R).
The slight decrease in thickness of the bioprinted stromal con-
structs can be related to the loss of mass from the bioinks observed
in the in vitro degradation data, which indicated that the bioink lost
roughly half of its mass after 8 days in medium (Supplementary
Fig. S4A). In the presence of 250 U/ml collagenase, the bioink
degraded completely in only 4 h, but degradation was slower in
more dilute collagenase concentrations (Supplementary Fig. S4B).
Finally, the matrix organization and composition of the 3D
bioprinted structures were studied from the frozen cross-sections
with IF staining and confocal imaging 7 days after printing. The
3D bioprinted structures showed positive labeling for collagen I and
VWF, indicating that the surrounding matrix of the hASCs is mainly
composed of human Col I and human plasma (Fig. 6A). High
magniﬁcation confocal images from the frozen cross-sections
showed horizontal and ﬁbrillary alignment of these matrix pro-
teins in the printed structures (Fig. 6B).
3.4. 3D bioprinted stromal structures show interaction and
attachment to host tissue in corneal organ culture
The functionality of 3D bioprinted corneal stroma mimicking
structures with hASCs was assessed using excised porcine corneas.
Large stromal wounds were inﬂicted, where 3D bioprinted struc-
tures were implanted 4 days after printing. Matriderm® supportive
sheets without hASCs were used as a control. In addition, the effect
of acellular bioink alone was studied in the corneal organ culture.
After 7 days in porcine corneal organ cultures, the 3D bioprinted
structures showed interaction and attachment to the host tissue
(Fig. 7A). Moreover, TRA-1-85 positive cells were detected in the
host stromal tissue, indicating possible cell migration of hASCs
from the printed structure (Fig. 7B). Strong adhesion of the printed
tissue to the host corneal stroma was also revealed (Fig. 7C). The
Matriderm® sheets alone and acellular bioink without hASCs
showed only minor interactionwith the host stroma (Fig. 7DeG). In
contrast to the Matriderm-containing bioprinted constructs, the
acellular bioink showed evidence of porcine epithelium over-
growth (Fig. 7GeI).
3.5. Laser-printed corneas from human stem cells resemble the
structure of native corneal tissue
Finally, we tested a proof-of-concept to fabricate tissue-
engineered cornea using both investigated human stem cell
types. Multiple layers of hESC-LESCs were printed on top of the
thicker 3D stromal structures containing hASCs. The corneal
structure printed using the Matrigel™ absorption layer showed
moderate transparency when printed on transparent PET substrate
(Fig. 8A). However, printing on non-transparent Matriderm® sup-
portive sheets was required to prevent the structure from shrinking
during culture (Fig. 8B). After 3 days of co-culture, the hESC-LESCs
showed a stratiﬁed, corneal progenitor marker p40 positive, layer
on the surface of the laser-printed structures (Fig. 8C). The trans-
parency of the constructs did not change during culture. The
thickness and structure of the printed epithelium in tissue-
engineered corneas resembled the structure of the uppermost
part of the native human cornea used as a control.
4. Discussion
3D bioprinting is a promising method for efﬁcient fabrication of
the layered cornea-mimicking structures. To our best knowledge,
only one previous study has assessed 3D bioprinting for corneal
tissue engineering, by using pressure-assisted bioprinting of
Fig. 4. Laser-assisted bioprinting of hASCs. Viability of hASCs printed as lines (A) and spots (B) after 1 day of printing. Live cells are shown in green and dead cells with red. Cell
proliferation of hASCs printed in lines after one and four days of printing (C). Cell morphology and migration (phalloidin¼ red) and proliferating cells (Ki67¼ green) of hASCs
printed in lines (D) and spots (E) at one and four days. Scale bars 1mm. The nuclei are visualized with DAPI (blue). (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the Web version of this article.)
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rat-tail Col I, gelatin and alginate [14]. In contrast, our approach
utilizes clinically relevant bioinks and two different human stem
cell types with potential for corneal regeneration. In this study, we
demonstrate the use of LaBP for producing native-like 3D cornea-
mimicking structures using human stem cells and functionalbiomaterials. We developed novel bioinks from recombinant and
human sourced materials for constructing 3D bioprinted corneal
epithelium-mimicking structures from hESC-LESCs and stroma-
mimicking structures from hASCs. Finally, we also tested a proof-
of-concept to fabricate a tissue-engineered cornea using both
stem cell types. To our knowledge, this is the ﬁrst study to exploit
Fig. 5. Constructing 3D corneal stroma mimicking structures using hASCs and laser-assisted bioprinting. Cell proliferation of hASCs in 3D bioprinted structure 1, 4 and 7 days after
printing (A) (***p < 0.001 and *p < 0.01). Top-view (B) and cross-section (C) of the live/dead-staining demonstrating the cell viability of hASCs in 3D the following day after printing
(live cells¼ green, dead cells¼ red). Proliferating cells (Ki67¼ green) visualized with immunoﬂuorescence staining from cryosection after four days of printing (D). Scale bars
500 mm (B-D). Human ASC distribution, morphology and orientation in 3D bioprinted structures visualized with phalloidin (red) from cryocross-Sections 2 days (E), 4 days (F), 7
days (G), 9 days (H) and 14 days (I) after printing. The human corneal stroma is shown as a control (J). Scale bars 200 mm (E-J). High-magniﬁcation confocal images of the cell
orientation in 3D bioprinted stroma after four days since printing (K) and in human corneal stroma (L). Vertical confocal sections of hASC in 3D bioprinted layered structure: cell
orientation in the 1st layer (M) and 2nd layer (N). 3D rotated confocal image (O) and confocal maximum intensity projection image (P) of the top-layers in the 3D bioprinted stroma
7 days after printing. Scale bars 50 mm (K-P). Hematoxylin and eosin staining of 3D bioprinted stroma at 7 days (Q) and central human corneal stroma (R). Scale bars 200 mm (Q-R).
(DAPI¼ blue). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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Fig. 6. Matrix composition of 3D bioprinted stroma 7 days after printing. Immunoﬂuorescence staining of cryocross-sections against human collagen I (Col I, green) and Von
Willebrandt factor (VWF, red) with low (A) and high (B) magniﬁcation confocal images. Human corneal stroma was used as a control. Scale bars 200 mm. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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LaBP with LIFT offers advantages over many other 3D bio-
printing technologies, such as printing high-resolution 3D struc-
tures from viscous bioinks [41,42]. With LaBP, we can also achieve
precise spatial organization of cells and use different cell types in
the same engineered construct. Previous studies have shown suc-
cessful bioprinting of both human induced pluripotent stem cells
(hiPSC) and hESCs using extrusion-based bioprinting platforms
[43e45]. These studies have shown that undifferentiated hPSCs can
be bioprinted without adversely affecting their biological functions
such as viability, proliferation, and pluripotency [44,45]. The results
presented in this study are also among the ﬁrst to describe suc-
cessful 3D bioprinting of hPSC-derived cells, as only one previous
work has presented printing of hPSC-derived hepatocyte-like cells
using a valve-based bioprinting process [44].
In this study, we introduced novel bioinks for 3D bioprinting
that show biocompatibility with human stem cells. For the basis ofthese bioinks, we chose natural components of the LESC basement
membrane and corneal extracellular matrix: human recombinant
laminin for printing hESC-LESCs, and human Col I for hASCs.
Neither recombinant laminin nor human collagen have been pre-
viously used as major components of bioinks in 3D bioprinting.
However, recombinant laminin-511 (LN511) and LN521 in the form
of protein coatings have been shown to enhance the in vitro
adhesion, migration, and proliferation of human limbal epithelial
cells [46], and LN521 is used in combination with Col IV for dif-
ferentiation of hESC-LESCs [20]. Col I is the major structural protein
of the corneal stroma, where it exists as highly arranged ﬁbrils [47].
Due to its major structural role in the native human corneal stroma,
collagen has been vigorously investigated for corneal bioengi-
neering [31]. Recently, human Col I and medical grade Col I bio-
engineered matrices have shown some promise in corneal tissue
engineering applications [48,49]. In addition, porcine Col I has been
investigated for use in corneal implants [19,50e52] In general, Col I
Fig. 7. 3D bioprinted stroma in porcine corneal organ culture model after 7 days (A-C). Blank Matriderm® sheets (D-F) and acellular bioink were used as control (G-I). Immu-
nohistochemical staining of human cell marker TRA-1-85 (brown) demonstrated successful hASC integration into the porcine corneal stroma from the 3D bioprinted stromal
mimicking structures, whereas for Matriderm® and acellular bioink only minor interaction with the stroma were observed. HE staining of the acellular bioink in organ culture
showed evidence of overgrowth of the porcine epithelium. Scale bars 200 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web
version of this article.)
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extensively used in 3D bioprinting in various applications
(reviewed in Refs. [35,53e55]). However, it has been previously
demonstrated that Col I from different sources show different ul-
trastructure and biomaterial properties and that the human Col I
requires special handling upon biomaterial fabrication compared to
bovine Col I [56]. Thus, results and fabrication parameters gained
with animal-derived Col I in 3D bioprinting applications are not
directly transferrable to use with the more clinically relevant hu-
man Col I. Here, we demonstrated the printability and biocom-
patibility of both LN521 and Col I based bioinks in LaBP.
Usually, bioinks require rapid crosslinking after 3D bioprinting
to develop self-supporting structures that maintain their desired
shape upon fabrication and in further culture [57]. In this study, we
produced stable 3D cornea-mimicking structures without further
crosslinking. For printing of hESC-LESCs, we utilized high viscosity
bioinks achieved through mixing of HA and cell culture medium to
LN521. The structures maintained their shape due to high viscositycaused by the presence of HA as well as high cell density. Despite
the lack of further crosslinking, the printed hESC-LESCs formed 3D
epithelium-mimicking tissue, which maintained its structure in
culture. Sufﬁcient stability for 3D bioprinted stromal structure from
Col I bioink and hASCs was established with human blood plasma
and thrombin coagulation during printing. Previously, the ﬁbrin-
thrombin coagulation reaction has been utilized for production of
biomaterials for primary LESC culture and transplantation [58], and
stabilization of 3D bioprinted skin [55,59]. In addition, gelatin/
ﬁbrin composite scaffolds stabilized in thrombin solution have
been shown to sustain 14 days of culture, although both gelatin and
ﬁbrin are bioresorbable and degrade enzymatically [60]. Notably,
the printed stromal mimicking structures showed extensive
shrinkage and lost their original form after a few days of culture,
unless printed on a Matriderm® supportive sheet. Even with the
Matriderm® supportive sheets, the thickness of the printed struc-
tures decreased in culture: after 14 days, structures with thickness
of 300 mm remained suggesting that further crosslinking of the Col I
Fig. 8. 3D cornea from hESC-LESCs and hASCs fabricated using laser-assisted bioprinting. The bioprinted 3D cornea fabricated on PET substrate (A) shows moderate transparency,
however printing on non-transparent Matriderm® substrate (B) was required to avoid shrinkage of the structure during culture. C shows comparison between the 3D bioprinted
corneal tissue and the native human cornea. Immunoﬂuorescence staining of cryocross-sections show multilayered structure of corneal progenitor marker p40 (red) positive hESC-
LESCs on top of 3D scaffold after two days since printing. Hematoxylin and eosin (HE)-staining shows the structure of the bioprinted tissue. Cryosections of human cornea were used
as a control. Scale bars in B 10mm and in C 200 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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mechanical stiffness. In order for the crosslinking not to obstruct
the LaBP, the crosslinking should be induced after suspending cells.
Photo-crosslinking of the printed corneal construct is one option to
increase the mechanical stiffness of the printed grafts. However, it
should be noted that these crosslinking methods require the
addition of a photo-initiators or chemical crosslinkers that could be
cytotoxic and may reduce cell survival in the 3D printed grafts
[61,62].
The structures fabricated by LaBP showed high resolution after
printing as well as functional cell maturation during culture. Initial
printability and biocompatibility studies of human Col I containing
bioink for printing hASC revealed cell organization in clearly visible
2D patterns with good cell viability. By day 4 in culture, the initial
printed patterns were not visible anymore, and cells showed high
proliferation marker expression, elongated cell morphology with
some degree of alignment. In the bioprinted epithelium-mimicking
structures, hESC-LESCs also maintained high viability and prolif-
eration after printing, and showed typical polygonal epithelial cell
morphology, and high expression of corneal progenitor markers
p63a and p40. Importantly, the printed hESC-LESCs maintained
their bioprinted 3D epithelial tissue structure with 3e4 cell layers
and showed notable maturation towards corneal epithelium with
apical expression of CK3 and basal expression of p63a and p40
within 12 days of culture. However, further studies are required to
fully address the functionality of the hESC-LESC formed epithelium
after 3D bioprinting.Formation of the corneal stromal mimicking structures was
achieved by bioprinting alternating layers of hASC-containing
bioink and acellular bioink. Human ASCs had organized uniformly
throughout the 3D structures and showed high proliferation and
viability after printing. Although the 3D bioprinted structures had
higher cell density than the native corneal stroma, the achieved cell
organization in 3D printed structures was similar. In future studies,
achieving more native like cell densities of corneal stroma could be
realized through optimization of bioprinting parameters such as
layer organization and thickness. The high-magniﬁcation confocal
images revealed that the hASCs had organized in layers with
alternating alignment, as in the native corneal stroma. Further-
more, these structures showed positive labeling for collagen I and
VWF, indicating horizontal and ﬁbrillar alignment of human Col I
and plasma in the printed structures. Interestingly, these ﬁbers
demonstrated some organization and arrangement in the 3D
environment, indicating that 3D bioprinting with LaBP is a prom-
ising fabrication method for corneal stromal mimicking structures.
Previously, lamellar collagen organization has been achieved by
culturing primary corneal stromal cells on aligned templates, but
these methods are time-consuming and resulting structures
limited in thickness [8,10,63]. As we did not crosslink the Col I
matrix during fabrication, the ﬁber-like Col I seen after printingwas
likely produced or remodeled by the printed hASCs in the 3D
structure. This could indicate functionality of these cells, as one of
the key functions of corneal stromal cells is to produce and modify
collagen ﬁbers to maintain the ﬁne stromal architecture [31].
A. Sorkio et al. / Biomaterials 171 (2018) 57e7170However, further studies are needed to fully address the func-
tionality of the hASCs, their collagen production and ECM remod-
eling with respect to the printed layer thickness in the 3D structure.
To assess the functionality of the 3D bioprinted stromal
mimicking structures with hASC, we implanted them into organ-
cultured porcine corneas. 7 days after implantation, the 3D bio-
printed stromal structures showed interaction and attachment to
the host tissue. Moreover, TRA-1-85 positive human cells were
detected in the host stromal tissue, indicating potential cell
migration of hASCs from the printed structure. In contrast, the
Matridem® sheet alone showed only modest interaction with the
stroma. Acellular bioink, on the other hand, showed evidence of
overgrowth of host epithelium indicating good biocompatibility of
the bioink. Importantly, successful implantation to the corneal or-
gan culture model demonstrated good mechanical robustness of
the 3D bioprinted structures, as they could withstand shipping
from Germany to Finland, as well as mechanical handling during
the implantation operation. Although additional means of ﬁxing
the implants in place were not used, the implanted hASCs showed
attachment to the stromal wound bed. However, further develop-
ment is required to achieve better surgically feasible structures,
focusing on ﬁnding suitable transfer substrates instead of the
Matriderm® sheets.
In the ﬁnal stage, we tested a proof-of-concept to fabricate
tissue-engineered cornea using both investigated human stem cell
types. We bioprinted layers of hESC-LESCs on top of the thicker 3D
stromal structures containing hASCs, and the resulting structures
resembled the uppermost part of the native cornea. After 3 days of
culture, the hESC-LESCs retained a corneal progenitor marker p40
positive layered epithelium, with four to six cell layers. However,
the co-culture conditions of these two cell types need to be
developed further [64,65] to enable longer culture periods in vitro,
while maintaining the corneal regenerative properties of both cell
types. For advanced in vitro functionality studies, such as barrier
properties and mechanical studies of the bioprinted corneal
structures, controlled differentiation and maturation towards
corneal stroma and epithelium in different layers of the printed
constructs are required. Importantly, new substrates for the bio-
printed corneal structures are needed for optimizing both trans-
parency and stability of the structures for proper realization of
clinically feasible bioprinted corneal grafts.
5. Conclusions
With this study, we demonstrate for the ﬁrst time the feasibility
of 3D LaBP for corneal applications using human stem cells, and
show successful fabrication of layered 3D bioprinted tissues
mimicking the structure of native corneal tissues. In addition, we
introduce novel human protein based bioinks for 3D bioprinting
that show biocompatibility with human stem cells. The fabricated
3D corneal structures also demonstrated good mechanical prop-
erties without additional bioink crosslinking after LaBP. The in vitro
and in vivo functionality of the 3D structures requires further
studies but feasibility of the approach shows promise in porcine
corneal organ culture.
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